Current Edition

news

Johnson &Johnson’s COVID-19 shot hit again as feds plan to tag Guillain-Barré warning on label: reports

Johnson & Johnson’s COVID-19 vaccine has encountered numerous setbacks ranging from manufacturing issues to an emergency safety review. Use of the vaccine hasn't...
Continue Reading →
Europe

SGS’s Outstanding Work Recognized by Customers at the CRO Leadership Awards 2021

For the fifth consecutive year, SGS Health Science has been recognized by the exclusive CRO Leadership Awards. In the 2021 awards, SGS was delighted to win three awa...
Continue Reading →
Europe

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Executives are extremely bullish on pharma’s business outlook for both the short and medium term Ahead of CPhI Discover (17th-28th May 2021) – global pharma’s larg...
Continue Reading →
Europe

SGS Facilitates Selecta Biosciences and AskBio’s FIH Study to Evaluate ImmTOR™ in Gene Therapy

SGS is pleased to announce the support of Selecta Biosciences and Asklepios BioPharmaceutical, Inc. (AskBio) Phase 1 dose-escalation trial of SEL-399, an adeno-...
Continue Reading →
news

CPhI Worldwide Announces New November 2021 Dates

At CPhI Worldwide, we understand the importance of meeting face-to-face with your peers and potential business partners.  In 2021 we will bring the global pharma comm...
Continue Reading →
news

Japan’s Kobayashi Kako admits manufacturing mix-up led to patient’s death

A "grave" manufacturing error in Japan tainted antifungal tablets with high doses of a sleep medication, leading to the death of one woman in her 70s and side effect...
Continue Reading →
news

AbbVie’s Botox wins reprieve as agency bars Evolus’ Jeaveau for alleged trade-secrets theft

AbbVie's aiming to make the most out of its new moneymaker Botox, gained in its Allergan megamerger last year, and it just scored a legal win—against ...
Continue Reading →
news

MacroGenics HER2 drug scores FDA breast cancer nod with Herceptin-topping data

MacroGenics’ oncology med Margenza is launching into the crowded HER2-positive breast cancer field. But the company has one advantage it can tout: The drug topped Ro...
Continue Reading →
news

Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren’t they getting to more patients?

About a month after the FDA issued emergency authorizations for COVID-19 antibodies from Eli Lilly and Regeneron, most of them have gone unused, a federal official s...
Continue Reading →
news

Biogen inks $22M charity kickbacks deal with feds, but argues its conduct was appropriate

Over the last few years, the federal government has inked charity kickback settlements with a who’s who of pharma companies. With a new Department of Justice settlem...
Continue Reading →